We were very grateful to have Regina Barzilay — one of the world’s leading AI/machine learning researchers and a Distinguished Professor for AI and Health at CSAIL MIT — join us recently to discuss the fast-evolving landscape of machine learning in drug discovery. Dr. Barzilay presented some of her own pioneering work in building AI models to optimize small-molecule drug design and protein engineering. She also joined a deeper discussion with our scientific team to explore the specific challenges and opportunities in molecular machine learning, one of the core computational approaches being advanced by our in-house data science team that informs our drug discovery work. Thank you, Dr. Barzilay, for sharing your insights and being a thought partner as we continue to push the bounds of what’s possible. #machinelearning #artificialintelligence #AI #biotechnology
Fantastic Pf.Regina Barzilay , we admire you as always
Chairman and CEO, FogPharma & Former Executive Vice President, Pharmaceuticals, R&D, Johnson & Johnson
2moThank you, Regina Barzilay